Synthesis and biological evaluation of hydroxycinnamic acid hydrazide derivatives as inducer of caspase-3

被引:14
作者
Wu, Zheng-Rong [1 ]
Liu, Jian [2 ]
Li, Jian-Ying [1 ]
Zheng, Li-Fang [1 ]
Li, Yang [1 ]
Wang, Xing [1 ]
Xie, Qing-Jian [3 ]
Wang, Ai-Xia [1 ]
Li, Ying-Hui [1 ]
Liu, Rong-Hui [3 ]
Li, Hong-Yu [1 ,3 ]
机构
[1] Lanzhou Univ, Sch Pharmaceut, Lanzhou 730000, Peoples R China
[2] Lanzhou Univ, Hosp 1, Lanzhou 730000, Peoples R China
[3] Lanzhou Univ, Sch Life Sci, Inst Microbiol, Lanzhou 730000, Peoples R China
关键词
Hydroxycinnamic acid hydrazide; Apoptosis; Caspase; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER; INHIBITION; CELLS;
D O I
10.1016/j.ejmech.2014.08.040
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In order to generate compounds with superior antitumor activity and reduced toxicity, twelve new hydroxycinnamic acid hydrazide derivatives were synthesized and evaluated for their antiproliferative activities against two cancer cell lines (H1299 lung carcinoma cells and MCF-7 breast cancer cells), and compared to two normal counterparts (NL-20 lung epithelial cells and H184B5F5/M10 breast cells) by MIT method. The results demonstrated that some of these compounds possessed good antiproliferative activity against the two cancer cell lines. Among them, compound 2c was active against the growth of H1299 lung carcinoma cells with IC50 values of 1.50 mu M, which was more active than the positive topotecan (IC50 = 4.18 mu M). Simultaneously, it showed lower cytotoxic effects on normal NL-20 lung epithelial cells (IC50 > 10 mu M). Mechanism studies indicated that it induced cell cycle arrest at G2/M phase followed by activation of caspase-3, and consequently caused the cell death. Further studies on the structure optimization are ongoing. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:778 / 783
页数:6
相关论文
共 24 条
[1]   Nanoparticle and targeted systems for cancer therapy [J].
Brannon-Peppas, L ;
Blanchette, JO .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (11) :1649-1659
[2]   Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[3]   Novel Cyano- and Amidinobenzothiazole Derivatives: Synthesis, Antitumor Evaluation, and X-ray and Quantitative Structure-Activity Relationship (QSAR) Analysis [J].
Caleta, Irena ;
Kralj, Marijeta ;
Marjanovic, Marko ;
Bertosa, Branimir ;
Tomic, Sanja ;
Pavlovic, Gordana ;
Pavelic, Kresimir ;
Karminski-Zamola, Grace .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) :1744-1756
[4]   Inhibition of apoptosis in polymorphonuclear neutrophils from burn patients [J].
Chitnis, D ;
Dickerson, C ;
Munster, AM ;
Winchurch, RA .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (06) :835-839
[5]   Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors [J].
Dallavalle, Sabrina ;
Cincinelli, Raffaella ;
Nannei, Raffaella ;
Merlini, Lucio ;
Morini, Gabriella ;
Penco, Sergio ;
Pisano, Claudio ;
Vesci, Loredana ;
Barbarino, Marcella ;
Zuco, Valentina ;
De Cesare, Michelandrea ;
Zunino, Franco .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (05) :1900-1912
[6]   Synthesis and evaluation of new phenolic-based antioxidants:: Structure-activity relationship [J].
de Pinedo, A. Torres ;
Penalver, P. ;
Morales, J. C. .
FOOD CHEMISTRY, 2007, 103 (01) :55-61
[7]   Biosynthesis, Natural Sources, Dietary Intake, Pharmacokinetic Properties, and Biological Activities of Hydroxycinnamic Acids [J].
El-Seedi, Hesham R. ;
El-Said, Asmaa M. A. ;
Khalifa, Shaden A. M. ;
Goransson, Ulf ;
Bohlin, Lars ;
Borg-Karlson, Anna-Karin ;
Verpoorte, Rob .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, 60 (44) :10877-10895
[8]  
Gajate C, 2000, CANCER RES, V60, P2651
[9]   New insights into the antioxidant activity of hydroxycinnamic acids: Synthesis and physicochemical characterization of novel halogenated derivatives [J].
Gaspar, Alexandra ;
Garrido, E. Manuela ;
Esteves, Mario ;
Quezada, Elias ;
Milhazes, Nuno ;
Garrido, Jorge ;
Borges, Fernanda .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (05) :2092-2099
[10]   Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: Association with p53 alterations, tumor angiogenesis, and tumor progression [J].
Grossfeld, GD ;
Carroll, PR ;
Lindeman, N ;
Meng, MW ;
Groshen, S ;
Feng, AC ;
Hawes, D ;
Cote, RJ .
UROLOGY, 2002, 59 (01) :97-102